A detailed history of Sei Investments CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sei Investments CO holds 643,828 shares of GILD stock, worth $58.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
643,828
Previous 603,981 6.6%
Holding current value
$58.1 Million
Previous $41.4 Million 30.23%
% of portfolio
0.07%
Previous 0.06%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$66.59 - $83.99 $2.65 Million - $3.35 Million
39,847 Added 6.6%
643,828 $54 Million
Q2 2024

Aug 13, 2024

SELL
$63.15 - $72.88 $6.39 Million - $7.38 Million
-101,229 Reduced 14.35%
603,981 $41.4 Million
Q1 2024

May 07, 2024

SELL
$71.58 - $87.29 $9.02 Million - $11 Million
-126,029 Reduced 15.16%
705,210 $51.7 Million
Q4 2023

Feb 14, 2024

SELL
$73.27 - $83.09 $1.77 Million - $2.01 Million
-24,189 Reduced 2.83%
831,239 $67.3 Million
Q3 2023

Nov 14, 2023

SELL
$73.94 - $80.67 $1.81 Million - $1.97 Million
-24,430 Reduced 2.78%
855,428 $64.1 Million
Q2 2023

Aug 11, 2023

SELL
$76.01 - $86.7 $690,854 - $788,016
-9,089 Reduced 1.02%
879,858 $67.8 Million
Q1 2023

May 12, 2023

BUY
$77.31 - $88.08 $5.12 Million - $5.84 Million
66,287 Added 8.06%
888,947 $73.8 Million
Q4 2022

Feb 10, 2023

BUY
$62.32 - $89.47 $8.21 Million - $11.8 Million
131,753 Added 19.07%
822,660 $70.6 Million
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $5.52 Million - $6.3 Million
92,657 Added 15.49%
690,907 $42.6 Million
Q2 2022

Aug 15, 2022

SELL
$57.72 - $65.01 $4.79 Million - $5.4 Million
-83,048 Reduced 12.19%
598,250 $36.9 Million
Q1 2022

May 13, 2022

SELL
$57.92 - $72.58 $28,728 - $35,999
-496 Reduced 0.07%
681,298 $40.5 Million
Q4 2021

Feb 14, 2022

SELL
$64.88 - $73.64 $6.05 Million - $6.86 Million
-93,216 Reduced 12.03%
681,794 $49.6 Million
Q3 2021

Nov 12, 2021

BUY
$67.69 - $73.03 $15.4 Million - $16.6 Million
226,785 Added 41.37%
775,010 $54.2 Million
Q2 2021

Aug 06, 2021

BUY
$63.47 - $69.35 $13 Million - $14.3 Million
205,534 Added 59.98%
548,225 $37.8 Million
Q1 2021

May 12, 2021

BUY
$60.0 - $68.46 $1.92 Million - $2.19 Million
32,044 Added 10.32%
342,691 $21.6 Million
Q4 2020

Feb 08, 2021

SELL
$56.65 - $64.55 $283,193 - $322,685
-4,999 Reduced 1.58%
310,647 $18.1 Million
Q3 2020

Dec 04, 2020

SELL
$62.1 - $78.08 $991,053 - $1.25 Million
-15,959 Reduced 4.81%
315,646 $20 Million
Q3 2020

Nov 06, 2020

SELL
$62.1 - $78.08 $1.91 Million - $2.4 Million
-30,730 Reduced 8.48%
331,605 $21 Million
Q2 2020

Aug 17, 2020

SELL
$72.34 - $84.0 $6.16 Million - $7.16 Million
-85,183 Reduced 19.03%
362,335 $27.9 Million
Q2 2020

Aug 11, 2020

BUY
$72.34 - $84.0 $6.85 Million - $7.95 Million
94,668 Added 26.83%
447,518 $30.8 Million
Q1 2020

May 14, 2020

SELL
$62.63 - $80.22 $2.4 Million - $3.08 Million
-38,365 Reduced 9.81%
352,850 $26.5 Million
Q4 2019

Feb 06, 2020

BUY
$61.62 - $67.78 $1.59 Million - $1.75 Million
25,840 Added 7.07%
391,215 $25.5 Million
Q3 2019

Nov 12, 2019

BUY
$62.51 - $69.0 $1.27 Million - $1.4 Million
20,310 Added 5.89%
365,375 $23.4 Million
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $1.26 Million - $1.42 Million
20,409 Added 6.29%
345,065 $23.5 Million
Q1 2019

May 15, 2019

BUY
$62.53 - $70.05 $1.27 Million - $1.43 Million
20,346 Added 6.69%
324,656 $21.3 Million
Q4 2018

Feb 13, 2019

BUY
$60.54 - $79.0 $2.66 Million - $3.47 Million
43,986 Added 16.9%
304,310 $22.6 Million
Q3 2018

Nov 08, 2018

SELL
$71.28 - $78.92 $10.5 Million - $11.6 Million
-147,483 Reduced 36.16%
260,324 $20.1 Million
Q2 2018

Aug 03, 2018

BUY
$64.88 - $75.68 $6.82 Million - $7.96 Million
105,146 Added 34.74%
407,807 $28.9 Million
Q1 2018

May 11, 2018

SELL
$72.84 - $88.8 $8.06 Million - $9.82 Million
-110,624 Reduced 26.77%
302,661 $22.8 Million
Q4 2017

Feb 08, 2018

BUY
$71.15 - $83.52 $3.73 Million - $4.38 Million
52,392 Added 14.52%
413,285 $29.6 Million
Q3 2017

Nov 06, 2017

BUY
$72.11 - $85.47 $26 Million - $30.8 Million
360,893
360,893 $29.2 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.